Haemonetics Corporation

314 articles about Haemonetics Corporation

• Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

  5/11/2023

  Haemonetics Corporation announced that financial results for its fourth quarter fiscal 2023, which ended April 1, 2023, are available on its Investor Relations website.

• Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023

  4/25/2023

  Haemonetics Corporation announced that the Company intends to publish fourth quarter and fiscal year 2023 financial results at 6:00 am ET on Thursday, May 11, 2023.

• Haemonetics Publishes Inaugural Corporate Responsibility Report

  4/20/2023

  Haemonetics Corporation today announced the release of its 2022 Corporate Responsibility Report.

• Haemonetics Introduces Next Generation Intelligent Control Software for Cell Saver® Elite®+ Autotransfusion System

  3/2/2023

  Haemonetics Corporation has announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on the next-generation software for the Cell Saver ® Elite ® + Autotransfusion System.

• Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference

  2/27/2023

  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 44th Annual Institutional Investors Conference on Monday, March 6, 2023, at 8:40 a.m. ET.

• Haemonetics 3rd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

  2/7/2023

  Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2023, which ended December 31, 2022, are available on its Investor Relations website.

• Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2023 Results: February 7, 2023

  1/6/2023

  Haemonetics Corporation announced that the Company intends to publish third quarter fiscal year 2023 financial results at 6:00 am ET on Tuesday, February 7, 2023.

• Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference

  12/19/2022

  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 10, 2023 at 2:15pm Pacific time.

• Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

  11/7/2022

  Haemonetics Corporation announced that financial results for its second quarter fiscal 2023, which ended October 1, 2022, are available on its Investor Relations website.

• Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022

  10/6/2022

  Haemonetics Corporation announced that the Company intends to publish second quarter fiscal year 2023 financial results at 6:00 am ET on Monday, November 7, 2022.

• Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center

  10/4/2022

  Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced the appointment of Roy Galvin as President, Global Plasma and Blood Center, effective October 10, 2022.

• Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio

  9/12/2022

  Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced it has earned CE mark certification for its VASCADE® vascular closure and VASCADE MVP® venous vascular closure systems.

• Haemonetics Announces Agreement to Offer Enhanced Transfusion Management Software to Epic's Global Network of Hospitals

  8/29/2022

  Haemonetics Corporation announced an agreement with Epic, a leading Electronic Health Record system, to offer Haemonetics' SafeTrace Tx® blood bank information system to Epic's global network of hospitals.

• Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

  8/23/2022

  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 8:45 a.m. ET.

• Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

  8/10/2022

  Haemonetics Corporation announced that financial results for its first quarter fiscal 2023, which ended July 2, 2022, are available on its Investor Relations website.

• Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2023 Results: August 10, 2022

  7/7/2022

  Haemonetics Corporation announced that the Company intends to publish first quarter fiscal year 2023 financial results at 6:00 am EDT on Wednesday, August 10, 2022.

• Haemonetics Completes Move to New Manufacturing Facility in Clinton, PA

  6/24/2022

  Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that it has fully commenced operations at its new manufacturing Center of Excellence in Clinton, PA.

• Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022

  6/6/2022

  Haemonetics Corporation has posted its full lineup of speakers planned for the Company's Investor Day, to be hosted in Boston on Wednesday, June 29, 2022, with presentations beginning at 10:00 AM EDT.

• Haemonetics to Host Investor Day Event on June 29, 2022

  5/10/2022

  Haemonetics Corporation announced that it will host an Investor Day in Boston on Wednesday, June 29, 2022 beginning at 10:00 AM EDT.

• Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

  5/10/2022

  Haemonetics Corporation announced that financial results for its fourth quarter fiscal 2022, which ended April 2, 2022, are available on its Investor Relations website.